NCT04651127 2026-03-10
Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer
Sun Yat-sen University
Phase 1/2 Terminated
Clinical Trials
10 trialsNCT07363330 2026-01-26
A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer
Zhongnan Hospital
Phase 2 Not yet recruiting
NCT06416696 2026-01-02
Toripalimab for High-risk Locally Advanced Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Active not recruiting
NCT05427396 2025-12-03
A Phase I Clinical Study of Recombinant Humanized Anti-BTLA Monoclonal Antibody (JS004) Injection Combined With Toripalimab Injection in Patients With Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Terminated
NCT06093438 2025-03-11
Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 1/2 Recruiting
NCT06256224 2024-04-24
Toripalimab Combined With Definitive CCRT for LACC Patients
Ruijin Hospital
Phase NA Recruiting
NCT05342506 2022-04-22
Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies
Peking Union Medical College Hospital
Phase 2 Unknown
NCT04973904 2021-07-22
Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT04395612 2021-05-21
CQGOG0101
Chongqing University Cancer Hospital
Phase 2 Unknown
NCT04368273 2020-04-29
CCRT+PD-1
Peking University Third Hospital
Phase 1/2 Unknown